Filler for smoker's lines: which upper-lip lines have product evidence?
So-called smoker's lines are vertical perioral wrinkles, whether or not a person smokes. Some exact fillers have FDA-reviewed upper-perioral-line uses, but lip volume, dynamic lines, etched lines, and lower-face folds need different endpoints.
Some specific hyaluronic-acid fillers have FDA-reviewed uses for upper perioral rhytids—the small vertical wrinkles around the upper lip—but “filler for smoker’s lines” is not a blanket approval for any syringe or every mouth crease. Restylane Kysse has a named upper-perioral-line indication in adults over 21; a separate RHA Redensity trial studied dynamic perioral lines. The right question is whether the visible target, exact product and measured endpoint match the offer, not whether a person has ever smoked.123
The nickname is imprecise and can be unfair. Vertical lines can reflect age, movement, skin change or other factors; the label describes an anatomic finding, not a smoking-history test. A consultation should use the neutral term perioral rhytids when discussing evidence.
Locate the lines before selecting a treatment category
| What the person sees | Different question to ask | Why it matters |
|---|---|---|
| Fine vertical lines above the upper lip | Are the lines visible at rest or mainly with movement? | Dynamic and etched-line studies may use different endpoints |
| Loss of lip fullness or definition | Is volume the goal rather than line texture? | Lip augmentation is a separate product indication and outcome |
| Lines radiating below a mouth corner | Is this a marionette fold or corner-position issue? | Lower-face evidence should not be relabeled upper-perioral evidence |
| Diffuse texture or sun-related pigment | Is the surface rather than a discrete wrinkle the concern? | A filler trial may not address that endpoint |
This map does not prescribe a modality. It ensures that a lip-volume quote is not presented as proof that fine lines will improve, and that a trial of one upper-lip line pattern is not generalized to every lower-face fold.
One exact FDA record is more useful than a category claim
The Restylane Kysse FDA SSED includes correction of upper perioral rhytids in patients older than 21. FDA’s general filler page identifies perioral lines as a site category separate from lip augmentation. Neither source says all HA fillers are interchangeable there or that the same product is approved for every line around the mouth.12
Ask to see the exact current product instructions, including indication, warnings, expected effects and follow-up. A practice may discuss off-label use of an approved filler, but it should not call the off-label site an FDA-approved indication. A compounded or imported material cannot borrow a named approved product’s regulatory record.
Read the trial by its outcome, not the photo
An original controlled RHA Redensity trial studied dynamic perioral rhytids and reported a stronger short-term responder result than untreated control at week eight. That supports a product- and endpoint-specific statement. It does not prove permanent smoothing, show that every static etched line responds the same way, or rank RHA against Restylane Kysse and every other option.3
Before-and-after images are most useful when they show the same expression, light, distance and timing. If a line appears mainly when the mouth moves, a still photograph at rest may miss the very endpoint a trial measured. Ask how the practice documents the particular line the person wants changed.
A quote should specify line correction, not just syringes
Request the product name, approved or off-label site, treatment goal, why that product suits the observed line, full-course quote and follow-up. A “lip filler” menu item may price volume enhancement; a perioral-line plan could have a different goal and risk discussion. Avoid assuming that more material means better line correction. FDA guidance calls for immediate medical attention if unusual pain, vision change, white/gray/blue skin near the site, or stroke signs appear during or shortly after injection; each is a separate warning sign.1
The marionette-line guide covers a lower-face fold, while the lip-flip-versus-filler comparison covers a volume-versus-movement choice. For upper perioral rhytids, ask a filler practice for the exact product, site and outcome. That is a clearer decision than the nickname “smoker’s lines.”
Sources
- U.S. Food and Drug Administration. Dermal Fillers (Soft Tissue Fillers). FDA distinguishes perioral lines from lip augmentation and explains site/product-specific filler uses and vascular risks. Accessed .
- U.S. Food and Drug Administration. Restylane Kysse upper perioral rhytids SSED. Exact approved upper-perioral-rhytid indication in patients older than 21; not a claim for every mouth crease or filler. Accessed .
- PubMed / original randomized trial. RHA Redensity for dynamic perioral rhytids. Product-specific controlled trial of dynamic perioral lines; its short-term responder endpoint does not rank all fillers or promise permanent correction. Accessed .